A private boarding school in rural western Massachusetts that opened in the 19th century is receiving a $50 million bequest ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

The Pentagon says the military services must again ask troops who were forced out or who voluntarily left the military due to ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

Aspira Women's Health Inc. (NASDAQ:AWH), a company specializing in diagnostic substances, has announced significant changes in its executive team. Dr. Sandra Milligan, the President of Aspira, will ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

The doctor beamed onto a health clinic video screen in October to convince the regional health board to ban public clinics in ...

Last week Pfizer announced that Ian Read is to step down as CEO, with chief operating officer Albert Bourla taking the helm. Following the change of leadership, Pfizer is also revamping its ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...